A steady environment ensures the peptides remain in optimal condition for research
Czarnywojtek A, Florek E, Pietronczyk K, Sawicka-Gutaj N, Ruchala M, Ronen O, Nixon IJ, Shaha AR, Rodrigo JP, Tufano RP, Zafereo ME , Randolph GW, Ferlito A
And the government needs to intervene, requiring Medicare to treat obesity as a chronic condition and initiating coverage for Part D enrollees who are prescribed a GIP or GLP-1 medication solely for the treatment of weight loss, rather than restricting coverage to those with diabetes or cardiovascular disease
Archived from the original on November 19, 2025
Declarations Ethics approval and consent to participate This article does not contain any studies with human participants or animals performed by any of the authors
Alqahtani Y, Wang S, Najmi A, Huang Y, Guan X